Double-blind comparison of cetirizine and loratadine in children ages 2 to 6 years with perennial allergic rhinitis

American Journal of Therapeutics

Volumn 6, Issue 3, 1999, Pages 149-155

  Sienra Monge, Juan José Luis ^a   Gazca Aguilar, Alfredo ^a   Del Rio Navarro, Blanca ^a  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

Author keywords

Antihistamines; Cetirizine; Efficacy; Loratadine; Perennial allergic rhinitis

Indexed keywords

CETIRIZINE; HISTAMINE; HOUSE DUST ALLERGEN; LORATADINE; POLLEN ANTIGEN;

ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EOSINOPHIL; FEMALE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; NOSE OBSTRUCTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RADIOALLERGOSORBENT TEST; RANDOMIZED CONTROLLED TRIAL; RASH; RHINORRHEA; SKIN TEST; SNEEZING; SOMNOLENCE;

EID: 0032951352     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199905000-00005     Document Type: Article

References (52)

1. Centers for Disease Control and Prevention: Vital and Health Statistics, Current Estimates From the National Health Interview Survey, 1994. DHHS publication PHS 96-1521. Washington, DC, US Dept of Health and Human Services, Public Health Service, National Center for Health Statistics, 1995.
2. Naclerio RM: Allergic rhinitis. N Engl J Med 1991;325: 860-869.
3. Ricketti AJ: Allergic rhinitis. In: Allergic Diseases: Diagnosis and Management, 3rd ed. (Ed. Patterson R), Philadelphia, JB Lippincott, 1980, pp 207-231.
4. Pearlman DS: Chronic rhinitis in children. J Allergy Clin Immunol 1988;81:962-966.
5. Georgitis JW: Allergic and non-allergic rhinitis: current concepts and treatment. Immunol Allergy Clin North Am 1987;7:221-234.
6. Allergy Practice Forum: Drug treatment for nasal allergy. Clin Exp Allergy 1989;19:559-568.
7. 1-receptor antagonist treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1990;86:1000-1003.
8. 1-receptor antagonists: clinical pharmacology and therapeutics. J Allergy Clin Immunol 1989; 84:845-861.
9. 1-receptor antagonists. Eur J Clin Pharmacol 1985;28:523-529.
10. Lockey RF, Findley S, Mitchell DQ, et al: Effects of cetirizine versus terfenadine in seasonal allergic rhinitis. Ann Allergy 1993;70:311-315.
11. Mansmann HC, Altman RA, Berman BA, et al: Efficacy and safety of cetirizine therapy in perennial allergic rhinitis. Ann Allergy 1992;68:348-353.
12. Backhouse CI, Renton R, Fidler C, et al: Multicentre, double-blind comparison of terfenadine and cetirizine in patients with seasonal allergic rhinitis. Br J Clin Pharmacol 1990;44:88-91.
13. Caiaffa MF, Iudice A, Macchia L, et al: Multicenter double-blind comparative study of terfenadine and cetirizine in hay fever. J Invest Allergol Clin Immunol 1992;2:162-166.
14. Lockey RF, Widlitz MD, Mitchell DQ, et al: Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1996;76:448-454.
15. Harcup JW, Hawkes G, Saul PA: The efficacy and sedative profile of astemizole and cetirizine in the treatment of grass pollen hayfever in general practice. Br J Clin Pharmacol 1993;47:131-135.
16. Berkowitz RB, Dockhorn R, Lockey R, et al: Comparison of efficacy, safety, and skin test inhibition of cetirizine and astemizole. Ann Allergy Asthma Immunol 1996;76: 363-368.
17. Braun JJ, Conraux C, Bebear JP, et al: Evaluation of the effectiveness and tolerability of loratadine in seasonal allergic rhinitis [in French]. C R Ther Pharmacol Clin (France) 1992;10/98:19-24.
18. Rijntjes E, Ghys L, Rihoux J-P: Astemizole and cetirizine in the treatment of seasonal allergic rhinitis: a comparative double-blind, multicentre study. J Int Med Res 1990; 18:219-224.
19. Chaweewan B, Jareonchai P, Dhorranintra B: A clinical comparison of cetirizine versus astemizole in perennial allergic rhinitis. Drug Invest 1993;5:222-223.
20. Allegra L, Paupe J, Wieseman HG, et al: Cetirizine for seasonal allergic rhinitis in children aged 2-6 years. Pediatr Allergy Immunol 1993;4:157-161.
21. Lobaton P, Moreno F, Coulie P: Comparison of cetirizine with astemizole in the treatment of perennial allergic rhinitis and study of the concomitant effect on histamine and allergen-induced wheal responses. Ann Allergy 1990;65:401-405.
22. Del Carpio J, Kabbash L, Turenne Y, et al: Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1989;84: 741-746.
23. Gutkowski A, Bedard P, Del Carpio J, et al: Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1988;81:902-907.
24. Olsen OT, Nüchel Petersen L, Høi L, et al: Comparison of loratadine and terfenadine in allergic seasonal rhinoconjunctivitis with emphasis on nasal stuffiness and peak flow. Arzneim-Forsch/Drug Res 1992;42:1227-2131.
25. Oei HD: Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action. Ann Allergy 1988;61:436-439.
26. Chervinsky P, Georgitis J, Banov C, et al: Once daily loratadine versus astemizole once daily. Ann Allergy 1994;73:109-113.
27. Irander K, Ödkvist LM, Ohlander B: Treatment of hay fever with loratadine - a new non-sedating antihistamine. Allergy 1990;45:86-91.
28. Bédard P-M, Del Carpio J, Drouin MA, et al: Onset of action of loratadine and placebo and other efficacy variables in patients with seasonal allergic rhinitis. Clin Ther 1992;14:268-275.
29. Kreutner W, Chapman RW, Gulbenkian A, et al: Antiallergic activity of loratadine, a non-sedating antihistamine. Allergy 1987;42:57-63.
30. Horak F, Bruttmann G, Pedrali P, et al: A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis. Arzneim-Forsch/Drug Res 1988;38:124-128.
31. Boner AL, Miglioranzi P, Richelli C, et al: Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis. Allergy 1989;44:437-441.
32. Watson WTA, Simons KJ, Chen XY, et al: Cetirizine: a pharmacokinetic and pharmacodynamic evaluation in children with seasonal allergic rhinitis. J Allergy Clin Immunol 1989;84:457-464.
33. Gengo FM, Gabos C, Mechtler L: Quantitative effects of cetirizine and diphenhydramine on mental performance measured using an automobile driving simulator. Ann Allergy 1990;64:520-526.
34. Seidel WF, Cohen S, Bliwise NG, et al: Cetirizine effects on objective measures of daytime sleepiness and performance. Ann Allergy 1987;59:58-62.
35. Roth T, Roehrs T, Koshorek G, et al: Sedative effects of antihistamines. J Allergy Clin Immunol 1987;80:94-98.
36. Dockhorn RJ, Bergner A, Connell JT, et al: Safety and efficacy of loratadine (Sch-29851): a new non-sedating antihistamine in seasonal allergic rhinitis. Ann Allergy 1987;58:407-411.
37. Meltzer EO, Weiler JM, Widlitz MD: Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97: 617-626.
38. Herman D, Arnaud A, Dry J, et al: Clinical effectiveness and tolerance of loratadine versus cetirizine in the treatment of seasonal allergic rhinitis [in French]. Allergy Immunol (Paris) 1992;24:270-274.
39. Tarchalska-Krynska B, Zawisza E: A 6-week, cross-over study comparing cetirizine and loratadine in seasonal allergic rhinitis [in Polish]. Pneumonol Alergol Pol 1994; 62:573-577.
40. Cave JP, Billardon M: Comparaison de l'efficacité de la céterizine à celle de la loratadine sur la rhinite saisonnière ou per-annuelle. Immunologie Médicale 1991;8:87-90.
41. 1 inhibiting effects of cetirizine 2 HCl and loratadine. Ann Allergy 1990;65:139-142.
42. Pechadre JC, Beudin P, Eschalier A, et al: A comparison of central and peripheral effects of cetirizine and loratadine. J Int Med Res 1991;19:289-295.
43. Simons FER, McMillan JL, Simons KJ: A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990;86:540-547.
44. Fadel R, Herpin-Richard N, Dufresne F, et al: Pharmacological modulation by cetirizine and loratadine of antigen and histamine-induced skin weals and flares, and late accumulation of eosinophils. J Int Med Res 1990;18: 366-371.
45. Roquet A, Raud J, Halldén G, et al: Effects of loratadine on anti-IgE-induced inflammation, histamine release, and leukocyte recruitment in skin of atopics. Allergy 1995;50:414-420.
46. Monahan BP, Ferguson CL, Killeavy ES, et al: Torsades de pointes occurring in association with terfenadine use. JAMA 1990;264:2788-2790.
47. Honig PK, Woosley RL, Zamani K, et al: Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992;52:231-238.
48. Goss JE, Ramo BW, Blake K: Torsades de pointes associated with astemizole (Hismanal) therapy. Arch Intern Med 1993;153:2705.
49. Rao KA, Adlakha A, Verma-Ansil B, et al: Torsades de pointes ventricular tachycardia associated with overdose of astemizole. Mayo Clin Proc 1994;69:589-593.
50. Sakemi H, VanNatta B: Torsades de pointes induced by astemizole in a patient with prolongation of the QT interval. Am Heart J 1993;125:1436-1438.
51. Sale ME, Barbey JT, Woosley RL, et al: Pharmacodynamics and drug action: the electrocardiographic effects of cetirizine in normal subjects. Clin Pharmacol Ther 1994; 56:295-301.
52. Brannan MD, Reidenberg P, Radwanski E, et al: Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluations. Clin Pharmacol Ther 1995;58:269-278.